
    
      The SAPPHYRE study is an ambispective (retrospective and prospective), non-interventional,
      multicenter, post-market clinical follow-up study. The study objective is to evaluate the
      safety and performance of Sophysa's CE marked PolarisÂ® 24 adjustable valve system in the
      treatment of hydrocephalus by shunting the cerebrospinal fluid. It is expected to recruit 126
      patients in two-year. Patients will be followed-up up to 5 years post-procedure.
    
  